-
-
An effective medicine against Hepatitis C, Daclatasvir from Natco, under the brand name Natdac, is a complete copy (generic) of the famous Daklinza. Daclatasvir is a high-class medicines aimed at fighting the “Hepatitis” virus of various types. The protein inhibitor blocks the spread of the virus through the bloodstream, thereby preventing the infection of healthy cells. In Russia, more than 15-16 million patients with hepatitis C. This Tablet has been found to work against chronic hepatitis C virus infection.
The maximum effectiveness of the medicine is achieved when used together with other antiviral agents. In general, use with Ribavirin and Sofosbuvir, the medicine Daclatasvir Natdac has the widest effect on stopping the process of increasing the amount of protein produced by the virus and preserving healthy, intact cells of the body. This method is extremely effective in the treatment of hepatitis C virus form.
Unfortunately, the cost of original Daclatasvir medicines in Russia and other countries around the world is a major serious concern. But the great relief is that generic medicine acts against the infection, to fight the disease in the same way as daklinza. Bristol-Myers Squibb has agreed to provide the licenses to several pharmaceutical companies in India to manufactures the generic versions of daklinza medicines. Now patients from Russia suffering from the hepatitis C could get more benefits from inexpensive generic medicines. Read more
-
You must be logged in to post a comment.